BY EXIGENCY and expectation, it was a day of reckoning. On January 16, India launched its first phase of vaccination for COVID-19. With two vaccines—Covaxin, manufactured by Bharat Biotech International Ltd, and Covishield, developed by the Oxford University and AstraZeneca—this phase was supposed to cover some 30 million healthcare and frontline workers. Prime Minister Narendra Modi launched the drive. He declared the day as the beginning of the end of COVID-19. And, as expected, he also celebrated it as an Indian accomplishment. “There are more than 100 countries having a population of less than three crore (30 million) and India is administering vaccination to three crore people in the first phase only,” he said.
But the prologue and epilogue to this day is jarring. Just two days before the Indian vaccination drive began, Norway reported 23 deaths related to its COVID-19 vaccination drive. Later in Israel, 13 people developed facial paralysis after getting vaccinated. By the time the first batch of healthcare workers were ready to take the jab across India, reports of hesitancy poured in. In Bihar, healthcare workers of three big medical colleges went on record saying that the vaccination drive had been marred. In Assam, Accredited Social Health Activists (ASHA) workers said they did not want to become guinea pigs. Similar reports came from Jammu and Kashmir, Kerala, Andhra Pradesh, Punjab, Himachal Pradesh and Haryana.
This story is from the {{IssueName}} edition of {{MagazineName}}.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the {{IssueName}} edition of {{MagazineName}}.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
Trade On Emissions
EU's Carbon Border Adjustment Mechanism, a tariff on imports, is designed to protect European industries in the guise of climate action.
'The project will facilitate physical and cultural decimation of indigenous people'
The Great Nicobar Project has all the hallmarks of a disaster-seismic, ecological, human. Why did it get the go-ahead?
TASTE IT RED
Popularity of Karnataka's red jackfruit shows how biodiversity can be conserved by ensuring that communities benefit from it
MANY MYTHS OF CHIPKO
Misconceptions about the Chipko movement have overshadowed its true objectives.
The politics and economics of mpox
Africa's mpox epidemic stems from delayed responses, neglect of its health risks and the stark vaccine apartheid
Emerging risks
Even as the world gets set to eliminate substances threatening the ozone layer, climate change and space advancement pose new challenges.
JOINING THE CARBON CLUB
India's carbon market will soon be a reality, but will it fulfil its aim of reducing emissions? A report by PARTH KUMAR and MANAS AGRAWAL
Turn a new leaf
Scientists join hands to predict climate future of India's tropical forests
Festering troubles
The Democratic Republic of Congo struggles to contain mpox amid vaccine delays, conflict and fragile healthcare.
India sees unusual monsoon patterns
THE 2024 southwest monsoon has, between June 1 and September 1, led to excess rainfall in western and southern states such as Gujarat, Maharashtra and Tamil Nadu, while others like Nagaland, Manipur and Punjab recorded a deficit.